Aplagon, a clinical-stage biotech developing first-in-class therapies for thromboinflammatory diseases, today announced the comprehensive publication of an invited review article in Arteriosclerosis, ...

Direct oral anticoagulants (DOACs) prescribed by GPs in Belgium frequently involved drug-drug interactions (DDIs), with nearly 18% of prescriptions containing at least one DDI and these DDIs affecting ...

While the three drugs accounted for less than 10% of all anticoagulant prescriptions, they are linked to more than 90% of deaths reported to the FDA since 2010, the analysis found. The numbers are ...

Blood-feeding animals rely on specific molecules in their saliva to overcome defense mechanisms of their mammalian hosts for successful survival. For example, tick saliva contains molecules that can ...

Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of blood clots, according to a retrospective ...

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that use of warfarin, a vitamin K drug widely prescribed to prevent blood clots, is associated ...

Michael B. Bottorff, PharmD: Fall risk is a major component of a discharge counseling strategy for patients who are newly being started on any anticoagulant, including a DOAC (direct oral ...

Researchers from Heidelberg University in Germany have found that anticoagulant drugs that inhibit thrombin (an enzyme used for clot formation) reduce the number of brain metastases (cancerous growths ...

Newly published research out of the University of Cincinnati and the University of California-Davis shows that direct oral anticoagulant (DOAC) drugs are more effective and are more cost-effective ...

Elite, a specialty pharmaceutical company engaged in the development, manufacture and distribution of niche generic products, has submitted an Abbreviated New Drug Application to the Food and Drug ...

Despite favourable results in pivotal clinical trials involving novel direct oral anticoagulants, vitamin K antagonists remain the most commonly prescribed anticoagulant. Newer oral anticoagulants are ...